Frontiers | The Intricate Innate Immune-Cancer Cell Relationship in the Context of Tumor Angiogenesis, Immunity and Microbiota: the Angiogenic Switch in the Tumor Microenvironment as a Key Target for Immunotherapies

The Intricate Innate Immune-Cancer Cell Relationship in the Context of Tumor Angiogenesis, Immunity and Microbiota: the Angiogenic Switch in the Tumor Microenvironment as a Key Target for Immunotherapies

37k
Total downloads
86k
Total views and downloads

Download PDF Download EPUB

Articles

EDITORIAL

Published on 06 Oct 2022

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

Lorenzo Mortara
Andrew V. Benest
Lisa Derosa
Salem Chouaib
Domenico Ribatti

doi 10.3389/fimmu.2022.1045074

1,037 views
3 citations

REVIEW

Published on 13 Sep 2022

Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment

Haiqiang Wang
Fan Shi
Shudan Zheng
Mei Zhao
Zimeng Pan
Li Xiong
Lihong Zheng

doi 10.3389/fonc.2022.896662

1,898 views
1 citation

REVIEW

Published on 06 Jul 2022

Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients

Denisa Baci
Elona Cekani
Andrea Imperatori
Domenico Ribatti
Lorenzo Mortara

doi 10.3389/fimmu.2022.914890

2,841 views
8 citations

REVIEW

Published on 20 Jun 2022

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?

Bassam Janji
Salem Chouaib

doi 10.3389/fimmu.2022.880810

3,302 views
7 citations

CASE REPORT

Published on 03 Mar 2022

Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma

Weiran Xu
Kai Wang
Wenguang Gu
Xinxin Nie
Hao Zhang
Chuanhao Tang
Li Lin
Jun Liang

doi 10.3389/fonc.2022.809068

2,225 views
10 citations

ORIGINAL RESEARCH

Published on 22 Feb 2022

Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer

Xin Qing
Wenjing Xu
Shengli Liu
Zhencheng Chen
Chunping Ye
Yewei Zhang

doi 10.3389/fimmu.2022.843077

17,792 views
67 citations

MINI REVIEW

Published on 10 Feb 2022

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside

Antonio Giovanni Solimando
Charis Kalogirou
Markus Krebs

doi 10.3389/fimmu.2022.842038

2,707 views
12 citations

REVIEW

Published on 08 Feb 2022

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?

Raefa Abou Khouzam
Rania Faouzi Zaarour
Klaudia Brodaczewska
Bilal Azakir
Goutham Hassan Venkatesh
Jerome Thiery
Stéphane Terry
Salem Chouaib

doi 10.3389/fimmu.2022.828875

5,755 views
44 citations

REVIEW

Published on 07 Jan 2022

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade

Carlo Genova
Chiara Dellepiane
Paolo Carrega
Sara Sommariva
Guido Ferlazzo
Paolo Pronzato
Rosaria Gangemi
Gilberto Filaci
Simona Coco
Michela Croce

doi 10.3389/fimmu.2021.799455

16,972 views
139 citations

ORIGINAL RESEARCH

Published on 14 Sep 2021

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer

Hao Zhang
Zeyu Wang
Ziyu Dai
Wantao Wu
Hui Cao
Shuyu Li
Nan Zhang
Quan Cheng

doi 10.3389/fimmu.2021.694490

4,058 views
31 citations

REVIEW

Published on 20 Aug 2021

The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?

Michela Roberto
Catia Carconi
Micaela Cerreti
Francesca Matilde Schipilliti
Andrea Botticelli
Federica Mazzuca
Paolo Marchetti

doi 10.3389/fimmu.2021.704942

3,165 views
6 citations

REVIEW

Published on 10 Aug 2021

Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner

Mikel Etxebeste-Mitxeltorena
Inés del Rincón-Loza
Beatriz Martín-Antonio

doi 10.3389/fimmu.2021.717850

4,770 views
13 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

86kTopic views
47kArticle views
37kArticle downloads

View impact

Submit your idea

Articles

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment

Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?

Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma

Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer

The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?

Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner

Frontiers in Immunology

Participating Journals

Impact